glp 1 dexcom Benefits of using CGM with GLP-1 drugs for diabetes treatment GLP-1 and Dexcom G7 CGM:

Among the 14 trials included, four excluded patients with heart failure, while the remaining nine articles excluded patients with heart failure, cardiac events (e.g., myocardial infarction, unstable angina, revascularization procedure, stroke) or cardiovascular diseases ( Supplementary Table 4 )

But injectable tirzepatide has been extensively studied and is FDA-approved for weight loss, type 2 diabetes, and obstructive sleep apnea

MESO_2408 study to assess the safety, efficacy and tolerance of the cosmetic product aox ferulic and nutraceutical product aox glutathione

Patel, S

Jess loves gutathione, for those without a CBS mutation who can handle sulfur products